The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of variation in sex steroid methyl transferases to predict efficacy of androgen-deprivation therapy (ADT) in advanced prostate cancer.
Manish Kohli
No relevant relationships to disclose
Douglas W. Mahoney
No relevant relationships to disclose
High Seng Chai
No relevant relationships to disclose
David W. Hillman
No relevant relationships to disclose
David R. Rider
No relevant relationships to disclose
Brian Addis Costello
No relevant relationships to disclose
James R. Cerhan
No relevant relationships to disclose